FreeCME

Expert Insights: Precision Medicine in Non-Small Cell Lung Cancer

CME: 0.5

June 1, 2022
/ Print / Reprints /
| Share More
/ Text Size+

Target Audience

This activity is designed to meet the educational needs of advanced practitioners (NP/PA), and other healthcare professionals involved in the care of patients with NSCLC.

Program Overview

This activity will highlight the most clinically relevant data presented during an independent satellite symposium in conjunction with the 2022 Oncology Nursing Society’s (ONS) Annual Conference and its potential impact on current and future strategies for managing patients with Non-Small Cell Lung Cancer.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Assess current biomarker testing guidelines for patients with NSCLC, including recommended strategies to detect common driver mutations
  • Review the safety and efficacy results of current and emerging targeted therapies for patients with NSCLC that harbor driver mutations
  • Discuss the value of multidisciplinary team communication and the inclusion of the patient as part of the care team

Post a comment to this article